Skip to main content

Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 17, 2024.

via HealthDay

THURSDAY, Oct. 17, 2024 -- For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published online Oct. 16 in Neurology.

Lina Palaiodimou, M.D., Ph.D., from the National and Kapodistrian University of Athens in Greece, and colleagues conducted a systematic review and meta-analysis of all available randomized controlled trials (RCTs) that examined the efficacy and safety of TNK 0.25 mg/kg versus TPA for treatment of AIS within 4.5 hours of onset. Data were included for 11 RCTs, with 3,788 patients treated with TNK and 3,757 patients treated with TPA.

The researchers found that compared with TPA, TNK was associated with a higher likelihood of excellent functional outcome (risk ratio, 1.05) and reduced disability at three months (common odds ratio, 1.10), while the groups had similar improved functional outcome. Similar rates of symptomatic intracranial hemorrhage and three-month mortality were observed in the groups. Statistical significance in achieving an excellent functional outcome at three months was retained for the original TNK when stratified for TNK regimen (original versus biocopy; risk ratio, 1.05).

"It demonstrates that TNK is associated with better clinical outcomes, showing superiority over TPA in achieving excellent functional outcome and reduced disability at three months. These findings support transitioning to TNK in clinical practice," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity

TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...

Delirium Common Among Critically Ill Patients With Stroke

TUESDAY, July 8, 2025 -- More than one in four critically ill patients with stroke experience delirium, according to a study published online July 1 in the American Journal...

A-Fib Catheter Ablation Cuts Risk for Ischemic Stroke After 30 Days, Mortality, Heart Failure Hospitalization

MONDAY, July 7, 2025 -- For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and heart failure...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.